drugset / Trial / NCT06524596
Study on Gynecological Laparoscopy Under Total Intravenous Anesthesia
RandomizedParallel-groupSingle-blindTreatment
Summary
To investigate the effect of preemptive analgesia with tartaric acid butorphanol on postoperative pain in gynecological laparoscopy under total intravenous anesthesia with remifentanil.This randomised, double-blind, placebo-controlled trial enrolled 60 patients undergoing elective gynaecological laparoscopy. The patients were divided into two groups: the butorphanol group (n = 30) and the control group (n = 29). Both groups received TIVA with propofol and remifentanil. Observing two groups of patients on the visual analog scale, the total consumption of rescue analogies, and the confidence of postoperative nausea and vomiting (PONV), and the patient satisfaction score.
Timeline
- Start
- 2022-01-01
- Primary completion
- 2022-12-31
- Completion
- 2023-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Butorphanol | Other / unclassified | 0.02 mg/kg | Intravenous |
| Background | Propofol | Small molecule | 2 mg/kg | — |
| Background | Remifentanil | Small molecule | 0.6 ug/kg | — |
Indications
No indication recorded.